Krystal Biotech, Inc.

KRYS US Health Care Biotechnology
S&P 600
$347.00
+0.42%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does Krystal Biotech, Inc. belong to?
Krystal Biotech, Inc. operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of KRYS?
As of the latest available quote, KRYS traded at $347.00. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of KRYS?
Krystal Biotech, Inc. has a price-to-earnings (P/E) ratio of about 43.48. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of KRYS?
The market capitalisation of Krystal Biotech, Inc. is approximately $10.39B.
Is Krystal Biotech, Inc. profitable?
For its latest reported financial year, Krystal Biotech, Inc. recorded a net profit margin of about 52.64%.
Does KRYS pay a dividend?
Krystal Biotech, Inc. does not currently show a dividend yield in our data.
What is the return on equity (ROE) of KRYS?
Krystal Biotech, Inc. has a return on equity (ROE) of about 15.07%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of KRYS?
Over the past 52 weeks, KRYS has traded between a low of $145.46 and a high of $382.54.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.